脑转移瘤影像组学研究质量:促进临床转化的路线图
该研究基于影像组学质量评分(RQS)、TRIPOD清单和IBSI指南,系统评价截至2021年2月发表的29篇脑转移瘤影像组学原始研究。结果显示仅3项(10.3%)进行外部验证,RQS中位数3.0(范围-6至12),TRIPOD依从率60.3%。作者结论为总体科学和报告质量不足,建议遵循上述指南以促进临床转化。
要点
- 仅10.3%的研究进行外部验证,RQS中位数3.0(范围-6至12),基本依从率50.0%。
- 无研究涉及重测信度、体模研究、前瞻性研究或成本效益分析。
- TRIPOD清单总体依从率60.3%,标题报告、盲法评估结局、缺失数据处理和全预测模型展示依从率均低。
核心结论
- 研究期间发表的脑转移瘤影像组学研究总体科学和报告质量不足;影像组学研究应遵循RQS、TRIPOD和IBSI指南以促进影像组学向临床领域转化。
研究设计与样本
- 检索PubMed MEDLINE和EMBASE截至2021年2月发表的脑转移瘤影像组学文章,从572篇中纳入29篇相关原始研究,依据RQS、TRIPOD清单和IBSI指南进行评价。
诊断标准与关键数值
- 外部验证仅3项研究(10.3%);RQS中位数3.0(范围-6至12),基本依从率50.0%;与「金标准」比较、声明潜在临床效用和提供开放科学与数据的依从率均为10.3%,进行cut-off分析的依从率为3.4%,报告校准统计量的依从率为6.9%;TRIPOD清单总体依从率60.3%,标题报告依从率3.4%,盲法评估结局、缺失数据处理描述和全预测模型展示的依从率均为0%;偏置场校正、等体素重采样、颅骨剥离和灰度离散化分别仅6项(20.7%)、9项(31.0%)、4项(3.8%)和4项(13.8%)研究执行。
临床应用与阅片要点
- 作者建议影像组学研究应遵循RQS、TRIPOD和IBSI指南,以促进影像组学向临床领域转化。
局限性
- 外部验证仅在3项研究(10.3%)中进行。
- RQS中位数为3.0(范围-6至12),基本依从率低至50.0%。
- 无研究涉及重测信度或体模研究、前瞻性研究或成本效益分析。
- TRIPOD清单总体依从率为60.3%,标题报告(3.4%)、盲法评估结局(0%)、缺失数据处理描述(0%)和全预测模型展示(0%)的依从率低。
- 多数研究缺乏预处理步骤,偏置场校正、等体素重采样、颅骨剥离和灰度离散化仅在6项(20.7%)、9项(31.0%)、4项(3.8%)和4项(13.8%)研究中执行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Our study aimed to evaluate the quality of radiomics studies on brain metastases based on the radiomics quality score (RQS), Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) checklist, and the Image Biomarker Standardization Initiative (IBSI) guidelines.
MATERIALS AND METHODS: PubMed MEDLINE, and EMBASE were searched for articles on radiomics for evaluating brain metastases, published until February 2021. Of the 572 articles, 29 relevant original research articles were included and evaluated according to the RQS, TRIPOD checklist, and IBSI guidelines.
RESULTS: External validation was performed in only three studies (10.3%). The median RQS was 3.0 (range, -6 to 12), with a low basic adherence rate of 50.0%. The adherence rate was low in comparison to the "gold standard" (10.3%), stating the potential clinical utility (10.3%), performing the cut-off analysis (3.4%), reporting calibration statistics (6.9%), and providing open science and data (3.4%). None of the studies involved test-retest or phantom studies, prospective studies, or cost-effectiveness analyses. The overall rate of adherence to the TRIPOD checklist was 60.3% and low for reporting title (3.4%), blind assessment of outcome (0%), description of the handling of missing data (0%), and presentation of the full prediction model (0%). The majority of studies lacked pre-processing steps, with bias-field correction, isovoxel resampling, skull stripping, and gray-level discretization performed in only six (20.7%), nine (31.0%), four (3.8%), and four (13.8%) studies, respectively.
CONCLUSION: The overall scientific and reporting quality of radiomics studies on brain metastases published during the study period was insufficient. Radiomics studies should adhere to the RQS, TRIPOD, and IBSI guidelines to facilitate the translation of radiomics into the clinical field.
引用
- Park CJ, Park YW, Ahn SS, et al. Quality of Radiomics Research on Brain Metastasis: A Roadmap to Promote Clinical Translation. Korean J Radiol. 2022. PMID: 34983096. doi:10.3348/kjr.2021.0421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。